Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCTD4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | VIMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | TXNL4A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | RCOR3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | RHOF | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | MIB1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | GIGYF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | OR9G1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | RP11-613M10.8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SLC35B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |